BioCentury
ARTICLE | Finance

Bugs in the clinic

Newco Seres first to the clinic in microbiome space, targeting C. difficile

November 25, 2013 8:00 AM UTC

Newco Seres Health Inc. has emerged from stealth mode, and the Flagship Ventures startup believes it already has at least one leg up on other microbiome companies - a program in the clinic.

Seres has been operating out of Flagship VentureLabs for two and a half years, CEO David Berry told BioCentury. Last week, the company disclosed it had raised $10.5 million in a series A round led by Flagship with participation from Enso Ventures...